Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1.
about
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assaysDiscovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor.Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.
P2860
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Optimization of 3-Pyrimidin-4- ...... t Specific Inhibitors of IDH1.
@en
Optimization of 3-Pyrimidin-4- ...... t Specific Inhibitors of IDH1.
@nl
type
label
Optimization of 3-Pyrimidin-4- ...... t Specific Inhibitors of IDH1.
@en
Optimization of 3-Pyrimidin-4- ...... t Specific Inhibitors of IDH1.
@nl
prefLabel
Optimization of 3-Pyrimidin-4- ...... t Specific Inhibitors of IDH1.
@en
Optimization of 3-Pyrimidin-4- ...... t Specific Inhibitors of IDH1.
@nl
P2093
P2860
P1476
Optimization of 3-Pyrimidin-4- ...... t Specific Inhibitors of IDH1.
@en
P2093
Arne Mueller
B Barry Touré
Brant Firestone
Fallon Lin
Fan S Yang
Gregg Chenail
John Giraldes
Joseph D Growney
P2860
P304
P356
10.1021/ACSMEDCHEMLETT.6B00334
P577
2016-12-16T00:00:00Z